![]() BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. | Zytoprotec Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach. | ||
Founding Date | Founding Date 2018 | Founding Date 1986 | Founding Date 2007 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations HQ | Locations Durham, US HQ Hoover, US | Locations Wien, AT HQ |
Employees | Employees 5 | Employees 14040% increase | Employees N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.9m | Total funding raised $ 2.7m |

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyZytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach.
View company